For subscribers
After being diagnosed with a deadly brain cancer, she joined a trial for an experimental vaccine. ‘Four years later, I’m still here.’
Experimental vaccine shows promise against deadly brain cancer in some patients
The vaccine, called SurVaxM, aims to prevent the recurrence of glioblastoma, an aggressive brain cancer with few major advances in treatment.
